Glycans decorate eukaryotic cell surface and secreted proteins, where they are poised to mediate a variety of molecular recognition events involved in attachment viruses and bacterial infection, immune cell activation, cancer metastasis and organ development. Many biological functions of cell-surface glycans can only be studied in the context of living cells. In addition to a glycan's primary structure, the architecture of its protein scaffold, as well as its density and distribution on the cell surface can all contribute to biological activity. Unfortunately, the heterogeneous nature of cell surfaces, particularly with respect to glycoconjugate structures, has frustrated molecular-level studies of glycan function. The controlled presentation of structurally defined glycoconjugates on live cells is therefore an important capability for accelerating research in glycobiology. The broad objective of this project is to develop chemical approaches for engineering cell surface glycan structures. During the previous granting period, we developed a method for controlling the activity of glycan biosynthetic enzymes in the Golgi compartment using the chemical inducer of dimerization strategy. We engineered Golgi sulfotransferases and glycosyltransferases for control by chemical dimerizers and demonstrated that cell surface expression of selectin ligands and blood group antigens can be modulated accordingly. We also developed a chemical dimerizer for applications in animal models. The next granting period we will focus three specific Aims. First, we will develop a method for site- specific chemical modification of cell surface proteins with synthetic, structurally-defined glycans. The method employs the 6-residue consensus sequence for formylglycine generating enzyme (FGE), which drives the formation of formylglycine (FGly) from a genetically encoded cysteine residue. The aldehyde functionality of FGly provides a uniquely reactive site to which synthetic aminooxy glycans can be ligated via oxime formation. We will use the "aldehyde tag" to modify recombinant cell surface proteins with tailored glycans. Applications to the construction of artificial cell surface mucins and to studies of the P-selectin ligand PSGL-1 are proposed.
The second Aim i nvolves application of the aldehyde tag to biophysical studies of the natural cell-surface mucin MUC1. The third and final Aim focuses on a second technology for engineering cell surface glycans. We plan to develop synthetic polymers that mimic mucin glycoproteins and to study their behavior when inserted into live cell membranes. We will investigate their cell surface dynamics and membrane orientations. The synthetic mucin mimics will then be applied to studies of siglec recognition and signaling.

Public Health Relevance

Complex sugars decorate the surfaces of cells, where they play a role in cell-cell interactions involved in normal biological processes and also in human disease. The goal of this research is to develop chemical tools for studying the functions of complex sugars on the cell surface. These tools will improve our understanding of how sugars contribute to diseases such as cancer and inflammation.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Synthetic and Biological Chemistry A Study Section (SBCA)
Program Officer
Marino, Pamela
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Berkeley
Schools of Arts and Sciences
United States
Zip Code
Smith, Elizabeth L; Giddens, John P; Iavarone, Anthony T et al. (2014) Chemoenzymatic Fc glycosylation via engineered aldehyde tags. Bioconjug Chem 25:788-95
Hudak, Jason E; Canham, Stephen M; Bertozzi, Carolyn R (2014) Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion. Nat Chem Biol 10:69-75
Paszek, Matthew J; DuFort, Christopher C; Rossier, Olivier et al. (2014) The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature 511:319-25
Hudak, Jason E; Bertozzi, Carolyn R (2014) Glycotherapy: new advances inspire a reemergence of glycans in medicine. Chem Biol 21:16-37
Mauris, Jerome; Mantelli, Flavio; Woodward, Ashley M et al. (2013) Modulation of ocular surface glycocalyx barrier function by a galectin-3 N-terminal deletion mutant and membrane-anchored synthetic glycopolymers. PLoS One 8:e72304
Belardi, Brian; de la Zerda, Adam; Spiciarich, David R et al. (2013) Imaging the glycosylation state of cell surface glycoproteins by two-photon fluorescence lifetime imaging microscopy. Angew Chem Int Ed Engl 52:14045-9
Agarwal, Paresh; van der Weijden, Joep; Sletten, Ellen M et al. (2013) A Pictet-Spengler ligation for protein chemical modification. Proc Natl Acad Sci U S A 110:46-51
Belardi, Brian; O'Donoghue, Geoff P; Smith, Adam W et al. (2012) Investigating cell surface galectin-mediated cross-linking on glycoengineered cells. J Am Chem Soc 134:9549-52
Hudak, Jason E; Yu, Helen H; Bertozzi, Carolyn R (2011) Protein glycoengineering enabled by the versatile synthesis of aminooxy glycans and the genetically encoded aldehyde tag. J Am Chem Soc 133:16127-35
Godula, Kamil; Bertozzi, Carolyn R (2010) Synthesis of glycopolymers for microarray applications via ligation of reducing sugars to a poly(acryloyl hydrazide) scaffold. J Am Chem Soc 132:9963-5

Showing the most recent 10 out of 43 publications